Patients are well served by Collis gastroplasty when indicated

Area of Science:

• Gastroenterology
• Surgical Oncology

Background:

• Debate exists regarding the impact of Collis gastroplasty (CG) on outcomes following anti-reflux surgery.
• This study evaluates operative and quality of life (QOL) outcomes in a large series of laparoscopic anti-reflux surgery (LARS) with CG.

Purpose of the Study:

• To compare the outcomes of LARS with CG versus LARS without CG.
• To assess the impact of CG on operative results and patient QOL.

Main Methods:

• A retrospective review of 480 patients undergoing LARS with (149) or without (331) CG.
• Data collected included demographics, perioperative details, and QOL using four validated surveys (RSI, GERD-HRQL, LPR-HRQL, SWAL-QL).

Main Results:

• Collis patients had longer operations and hospital stays but equivalent 30-day readmission and reoperation rates.
• Wound and non-wound complications were comparable between groups.
• Mean 12-month follow-up showed significant QOL improvements in all patients, with comparable results between Collis and non-Collis groups. CG did not increase post-operative dysphagia, reflux, or leak rates.

Conclusions:

• Collis gastroplasty is a safe and effective adjunct for LARS in patients with a true short esophagus.
• Patients requiring CG experience similar operative and QOL benefits to those without CG, without increased morbidity or mortality.